India  

Russia, Dr Reddy’s tie up for Sputnik V trial

IndiaTimes Wednesday, 16 September 2020 ()
Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on clinical trials and distribution of Sputnik V vaccine in India with deliveries for general use potentially beginning late this year.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News

Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News 01:03

Dr Reddy's and the Russian Direct Investment Fund (RDIF) have agreed to conduct clinical trials and distribute 100 million doses of Russia's Sputnik V Covid-19 vaccine in India. The RDIF is Russia's sovereign wealth fund. Upon regulatory approval in India, the RDIF shall supply to Dr Reddy’s 100...

You Might Like


Related videos from verified sources

Russia approves Covid-19 vaccine 'Sputnik V': Why's the world sceptical? [Video]

Russia approves Covid-19 vaccine 'Sputnik V': Why's the world sceptical?

Russia has become the first country to approve a Covid-19 vaccine and it has been named 'Sputnik V'. Russian President Vladimir Putin said that the vaccine was effective and said that one of his..

Credit: HT Digital Content     Duration: 03:03Published

Tweets about this